Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I7P3
Term | Name | Level | Count |
---|---|---|---|
GO:0006355 | regulation of DNA-templated transcription | 6 | 11 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 11 |
GO:0009889 | regulation of biosynthetic process | 4 | 11 |
GO:0010468 | regulation of gene expression | 5 | 11 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 11 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 11 |
GO:0019222 | regulation of metabolic process | 3 | 11 |
GO:0031323 | regulation of cellular metabolic process | 4 | 11 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 11 |
GO:0050789 | regulation of biological process | 2 | 11 |
GO:0050794 | regulation of cellular process | 3 | 11 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 11 |
GO:0051252 | regulation of RNA metabolic process | 5 | 11 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 11 |
GO:0065007 | biological regulation | 1 | 11 |
GO:0080090 | regulation of primary metabolic process | 4 | 11 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 11 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 11 |
GO:0010564 | regulation of cell cycle process | 5 | 1 |
GO:0032465 | regulation of cytokinesis | 5 | 1 |
GO:0051302 | regulation of cell division | 4 | 1 |
GO:0051726 | regulation of cell cycle | 4 | 1 |
GO:1902412 | regulation of mitotic cytokinesis | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 5 | 11 |
GO:0019207 | kinase regulator activity | 3 | 11 |
GO:0019887 | protein kinase regulator activity | 4 | 11 |
GO:0030234 | enzyme regulator activity | 2 | 11 |
GO:0098772 | molecular function regulator activity | 1 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.447 |
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.445 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.561 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.379 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.343 |
CLV_PCSK_FUR_1 | 261 | 265 | PF00082 | 0.428 |
CLV_PCSK_KEX2_1 | 174 | 176 | PF00082 | 0.447 |
CLV_PCSK_KEX2_1 | 207 | 209 | PF00082 | 0.445 |
CLV_PCSK_KEX2_1 | 263 | 265 | PF00082 | 0.452 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.434 |
CLV_PCSK_PC1ET2_1 | 263 | 265 | PF00082 | 0.445 |
CLV_PCSK_SKI1_1 | 122 | 126 | PF00082 | 0.372 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.322 |
DOC_CKS1_1 | 181 | 186 | PF01111 | 0.330 |
DOC_CYCLIN_yClb3_PxF_3 | 21 | 29 | PF00134 | 0.550 |
DOC_MAPK_gen_1 | 46 | 56 | PF00069 | 0.384 |
DOC_MAPK_gen_1 | 72 | 79 | PF00069 | 0.297 |
DOC_MAPK_MEF2A_6 | 122 | 131 | PF00069 | 0.362 |
DOC_PP4_FxxP_1 | 18 | 21 | PF00568 | 0.632 |
DOC_PP4_FxxP_1 | 181 | 184 | PF00568 | 0.308 |
DOC_PP4_FxxP_1 | 249 | 252 | PF00568 | 0.474 |
DOC_USP7_MATH_1 | 213 | 217 | PF00917 | 0.513 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.603 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.610 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.327 |
DOC_WW_Pin1_4 | 285 | 290 | PF00397 | 0.530 |
DOC_WW_Pin1_4 | 9 | 14 | PF00397 | 0.500 |
LIG_14-3-3_CanoR_1 | 150 | 156 | PF00244 | 0.460 |
LIG_14-3-3_CanoR_1 | 193 | 202 | PF00244 | 0.386 |
LIG_14-3-3_CanoR_1 | 32 | 40 | PF00244 | 0.462 |
LIG_14-3-3_CanoR_1 | 49 | 56 | PF00244 | 0.424 |
LIG_Actin_WH2_2 | 135 | 152 | PF00022 | 0.426 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.647 |
LIG_BRCT_BRCA1_1 | 14 | 18 | PF00533 | 0.672 |
LIG_BRCT_BRCA1_1 | 276 | 280 | PF00533 | 0.677 |
LIG_BRCT_BRCA1_1 | 283 | 287 | PF00533 | 0.649 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.438 |
LIG_FHA_1 | 233 | 239 | PF00498 | 0.439 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.395 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.426 |
LIG_FHA_2 | 152 | 158 | PF00498 | 0.471 |
LIG_LIR_Apic_2 | 15 | 21 | PF02991 | 0.631 |
LIG_LIR_Apic_2 | 180 | 184 | PF02991 | 0.307 |
LIG_LIR_Apic_2 | 216 | 221 | PF02991 | 0.438 |
LIG_LIR_Gen_1 | 134 | 145 | PF02991 | 0.476 |
LIG_LIR_Gen_1 | 197 | 206 | PF02991 | 0.448 |
LIG_LIR_Gen_1 | 212 | 221 | PF02991 | 0.499 |
LIG_LIR_Gen_1 | 240 | 249 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 134 | 140 | PF02991 | 0.479 |
LIG_LIR_Nem_3 | 197 | 203 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 212 | 217 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 240 | 245 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 27 | 33 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 284 | 290 | PF02991 | 0.655 |
LIG_OCRL_FandH_1 | 241 | 253 | PF00620 | 0.477 |
LIG_Pex14_2 | 139 | 143 | PF04695 | 0.483 |
LIG_Pex14_2 | 177 | 181 | PF04695 | 0.306 |
LIG_Pex14_2 | 214 | 218 | PF04695 | 0.464 |
LIG_SH2_CRK | 200 | 204 | PF00017 | 0.430 |
LIG_SH2_SRC | 22 | 25 | PF00017 | 0.574 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.584 |
LIG_SH2_STAT5 | 244 | 247 | PF00017 | 0.487 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.238 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.593 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.610 |
LIG_SUMO_SIM_anti_2 | 126 | 131 | PF11976 | 0.469 |
LIG_SUMO_SIM_par_1 | 123 | 128 | PF11976 | 0.462 |
LIG_TRAF2_1 | 165 | 168 | PF00917 | 0.470 |
LIG_TYR_ITIM | 198 | 203 | PF00017 | 0.440 |
LIG_WRC_WIRS_1 | 178 | 183 | PF05994 | 0.307 |
LIG_WRC_WIRS_1 | 23 | 28 | PF05994 | 0.564 |
MOD_CDK_SPxxK_3 | 285 | 292 | PF00069 | 0.666 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.571 |
MOD_CK1_1 | 151 | 157 | PF00069 | 0.464 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.329 |
MOD_CK1_1 | 216 | 222 | PF00069 | 0.495 |
MOD_CK1_1 | 278 | 284 | PF00069 | 0.555 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.641 |
MOD_CK2_1 | 151 | 157 | PF00069 | 0.464 |
MOD_CK2_1 | 216 | 222 | PF00069 | 0.476 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.506 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.560 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.487 |
MOD_GSK3_1 | 209 | 216 | PF00069 | 0.454 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.578 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.576 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.316 |
MOD_N-GLC_1 | 109 | 114 | PF02516 | 0.404 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.357 |
MOD_NEK2_1 | 145 | 150 | PF00069 | 0.369 |
MOD_NEK2_1 | 177 | 182 | PF00069 | 0.307 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.305 |
MOD_NEK2_1 | 201 | 206 | PF00069 | 0.452 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.481 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.197 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.304 |
MOD_PIKK_1 | 264 | 270 | PF00454 | 0.604 |
MOD_PIKK_1 | 31 | 37 | PF00454 | 0.463 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.463 |
MOD_PKA_2 | 48 | 54 | PF00069 | 0.424 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.406 |
MOD_Plk_4 | 213 | 219 | PF00069 | 0.487 |
MOD_Plk_4 | 275 | 281 | PF00069 | 0.638 |
MOD_Plk_4 | 50 | 56 | PF00069 | 0.324 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.610 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.329 |
MOD_ProDKin_1 | 285 | 291 | PF00069 | 0.533 |
MOD_ProDKin_1 | 9 | 15 | PF00069 | 0.500 |
MOD_SUMO_for_1 | 88 | 91 | PF00179 | 0.424 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.444 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.403 |
TRG_ER_diArg_1 | 173 | 175 | PF00400 | 0.446 |
TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.434 |
TRG_NES_CRM1_1 | 133 | 147 | PF08389 | 0.421 |
TRG_NES_CRM1_1 | 230 | 240 | PF08389 | 0.470 |
TRG_NLS_Bipartite_1 | 247 | 267 | PF00514 | 0.396 |
TRG_NLS_Bipartite_1 | 28 | 50 | PF00514 | 0.322 |
TRG_NLS_MonoExtN_4 | 261 | 267 | PF00514 | 0.440 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PFK2 | Leptomonas seymouri | 77% | 100% |
A0A1X0NWC7 | Trypanosomatidae | 33% | 100% |
A0A2D1QVA3 | Leishmania donovani | 100% | 100% |
A0A422N086 | Trypanosoma rangeli | 35% | 100% |
A4HK57 | Leishmania braziliensis | 92% | 100% |
D0A9U6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
E9B2K0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q4Q5K6 | Leishmania major | 95% | 100% |
V5BFB1 | Trypanosoma cruzi | 36% | 100% |